Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to test tetrandrine tablets for connective tissue disease–related interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrandrine (tetrandrine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease | Phase 4 | Status: RECRUITING